Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Walsh

Showing results (1151-1160 of 1,300) with videos related to

Pageof 130
Sort By:
Human Molecular Genetics|August 1, 2000
Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategyA M Isaacs, K E Davies, A J Hunter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2024
Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and managementF Tetart, S Walsh, B Milpied, et al.
JAMA|October 7, 2011
Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)Moronke A Noah, Giles J Peek, Simon J Finney, et al.
Lancet (London, England)|May 10, 2015
Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSPMark E Fraley, Robert M Garbaccio, Kenneth L Arrington, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSPPaul J Coleman, John D Schreier, Christopher D Cox, et al.
BMJ Open|October 23, 2021
Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional studyEmma A Hurst, Richard J Mellanby, Ian Handel, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubilityRobert M Garbaccio, Mark E Fraley, Edward S Tasber, et al.
Intensive Care Medicine|October 7, 2018
Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort studyManu Shankar-Hari, Deepankar Datta, Julie Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2006
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6Mark E Fraley, Justin T Steen, Edward J Brnardic, et al.
Pageof 130

Showing results (1151-1160 of 1,300) with videos related to

Sort By:
Pageof 130
Human Molecular Genetics|August 1, 2000
Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategyA M Isaacs, K E Davies, A J Hunter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 18, 2024
Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and managementF Tetart, S Walsh, B Milpied, et al.
JAMA|October 7, 2011
Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)Moronke A Noah, Giles J Peek, Simon J Finney, et al.
Lancet (London, England)|May 10, 2015
Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSPMark E Fraley, Robert M Garbaccio, Kenneth L Arrington, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSPPaul J Coleman, John D Schreier, Christopher D Cox, et al.
BMJ Open|October 23, 2021
Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional studyEmma A Hurst, Richard J Mellanby, Ian Handel, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubilityRobert M Garbaccio, Mark E Fraley, Edward S Tasber, et al.
Intensive Care Medicine|October 7, 2018
Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort studyManu Shankar-Hari, Deepankar Datta, Julie Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2006
3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6Mark E Fraley, Justin T Steen, Edward J Brnardic, et al.
Pageof 130